Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants
-
Lexaria Bioscience Corp. (NASDAQ: LEXX) Completes $2 Million Public Offering Consisting of Common Shares and Accompanying Warrants
-
iSpecimen to Participate in Maxim’s Healthcare IT Virtual Conference on June 1, 2023
-
mCloud Technologies (MCLD) Provides Update from Special Committee Exploring Strategic Alternatives
-
mCloud Provides Update from Special Committee Exploring Strategic Alternatives
-
Applied UV Reports Q1, 2023 Financial Results
-
Daxor Corp. (DXR) Prices 410K Share Offering at $9.75/sh
-
Daxor Corporation Announces Pricing of $4.0 Million Underwritten Public Offering
-
Daxor Corp. (DXR) Announces Proposed Stock Offering, Size not Disclosed
-
Daxor Corporation Announces Proposed Underwritten Public Offering
-
Augmedix Announces Participation in Upcoming Investor Conferences
-
SunCar (SDA) Completes Business Combination with Goldenbridge Acquisition Limited (GBRG) to Become Publicly Traded Company
-
SunCar Completes Business Combination with Goldenbridge Acquisition Limited to Become Publicly Traded Company
-
Acurx Pharmaceuticals (ACXP) Prices 1.33M Share Offering at $3/sh
-
Acurx Pharmaceuticals, Inc. Announces Pricing of $4.0 Million Registered Direct Offering
-
Maxim Research Update: Society Pass (Nasdaq: SOPA) - Compelling Valuation; 1Q23 EBITDA Beats Forecast
-
Maxim Research Update: Society Pass (Nasdaq: SOPA) – Compelling Valuation; 1Q23 EBITDA Beats Forecast
-
Maxim Research Update: Society Pass (Nasdaq: SOPA) - Compelling Valuation; 1Q23 EBITDA Beats Forecast
-
Ocean Biomedical (OCEA) Enters $25M Convertible Note Facility
-
Ocean Biomedical, Inc. Enters into a $25 Million Convertible Note Facility
-
SAI.TECH to Participate in the Bitcoin Mining Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Tuesday, May 16th at 9:00 A.M. ET
-
FCM Director Nominees Will Put MindMed Drug Development Process Back on Track
-
Canaan Inc. to Participate in the Bitcoin Mining Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Tuesday, May 16, 2023
-
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Secures $2M in Public Offering
-
Lexaria Bioscience Announces Closing of $2.0 Million Public Offering
-
LM Funding America, Inc. to Participate in the Bitcoin Mining Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Tuesday, May 16th at 9:00 A.M. ET
-
Draganfly Announces First Quarter Results of 2023
-
CareCloud's Bill Korn, Chief Strategy Officer, and Joseph DosSantos, Chief Financial Officer, to Host Investor Meetings at Upcoming Conferences
-
DMG Announces April Mining Results; Participation in the Bitcoin Mining Virtual Conference On May 16
-
Lexaria Bioscience (LEXX) Prices 2.1M Share Offering at $0.95/sh
-
Lexaria Bioscience Announces Pricing of $2.0 Million Public Offering
-
cbdMD Announces Closing of $2.8 Million Underwritten Public Offering of Common Stock
-
Regentis Biomaterials to Go Public via Merger with OceanTech Acquisitions I (OTEC)
-
Regentis Biomaterials Ltd to Become Publicly Listed on Nasdaq via Business Combination with OceanTech Acquisitions I Corp.
-
Esports Entertainment Group Announces Agreement to Complete $4.3 Million Private Placement
-
cbdMD Announces Pricing of $2.8 Million Underwritten Public Offering of Common Stock
-
cbdMD Announces Proposed Public Offering of Common Stock
-
ARB IOT Group Limited Announces Exercise and Closing of Over-Allotment Option in Initial Public Offering
-
ARB IOT Group Limited Announces Exercise and Closing of Over-Allotment Option in Initial Public Offering
-
ReShape Lifesciences (RSLS) Prices $2.5M Offering at $3.07/sh
-
ReShape Lifesciences Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market
-
ReShape Lifesciences Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market
-
The Power Play by The Market Herald Releases New Interviews with Reunion Gold Corp, Numinus Wellness, Core Assets, Blockmate Ventures, BioVaxys Tech, Carlyle Commodities and Belmont Resources Discussi
-
China Jo-Jo Drugstores (CJJD) Announces $7M Stock Offering at $3.10/sh
-
China Jo-Jo Drugstores Announces $7 Million Registered Direct Offering
-
BIOVAXYS RETAINS MAXIM GROUP AS FINANCIAL ADVISOR AND INVESTMENT BANKER
-
Trust Stamp (IDAI) Announces Pricing of $5.2 Million Registered Direct Offering of Common Stock, Warrants
-
Trust Stamp Announces Pricing of $5.2 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market
-
Trust Stamp Announces Pricing of $5.2 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market
-
Worksport CEO Steven Rossi Recaps Company Progress at Electric Vehicle and Auto Tech Virtual Conference

